113 related articles for article (PubMed ID: 1981663)
1. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.
Peters W; Ekong R; Robinson BL; Warhurst DC; Pan XQ
Ann Trop Med Parasitol; 1990 Dec; 84(6):541-51. PubMed ID: 1981663
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro.
Basco LK; Ringwald P; Le Bras J
Ann Trop Med Parasitol; 1991 Apr; 85(2):223-8. PubMed ID: 1686703
[TBL] [Abstract][Full Text] [Related]
3. Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum.
Peters W; Ekong R; Robinson BL; Warhurst DC; Pan XQ
Lancet; 1989 Aug; 2(8658):334-5. PubMed ID: 2569137
[No Abstract] [Full Text] [Related]
4. The chemotherapy of rodent malaria. LIX. Drug combinations to impede the selection of drug resistance, Part 3: Observations on cyproheptadine, an antihistaminic agent, with chloroquine.
Peters W; Robinson BL; Stewart LB; Butcher GA
Ann Trop Med Parasitol; 2000 Oct; 94(7):689-97. PubMed ID: 11144810
[TBL] [Abstract][Full Text] [Related]
5. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis.
Singh N; Puri SK
Acta Trop; 2000 Nov; 77(2):185-93. PubMed ID: 11080509
[TBL] [Abstract][Full Text] [Related]
6. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys.
Kyle DE; Milhous WK; Rossan RN
Am J Trop Med Hyg; 1993 Jan; 48(1):126-33. PubMed ID: 8427381
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
Biot C; Glorian G; Maciejewski LA; Brocard JS
J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.
Ndifor AM; Howells RE; Bray PG; Ngu JL; Ward SA
Antimicrob Agents Chemother; 1993 Jun; 37(6):1318-23. PubMed ID: 8328780
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo.
Peters W; Robinson BL; Rossier JC; Misra D; Jefford CW; Rossiter JC
Ann Trop Med Parasitol; 1993 Feb; 87(1):9-16. PubMed ID: 8346994
[TBL] [Abstract][Full Text] [Related]
10. Reversal of chloroquine resistance with verapamil in P. berghei in vivo.
Valecha N; Biswas S; Dewan S; Bhambhani S
Indian J Malariol; 1992 Mar; 29(1):47-53. PubMed ID: 1459299
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
12. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers.
Peters W; Robinson BL; Mittelholzer ML; Crevoisier C; Stürchler D
Ann Trop Med Parasitol; 1995 Oct; 89(5):465-8. PubMed ID: 7495359
[TBL] [Abstract][Full Text] [Related]
13. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
Peters W; Robinson BL; Milhous WK
Ann Trop Med Parasitol; 1993 Dec; 87(6):547-52. PubMed ID: 8122915
[TBL] [Abstract][Full Text] [Related]
14. High-level chloroquine resistance of Plasmodium berghei is associated with multiple drug resistance and loss of reversal by calcium antagonists.
Platel DF; Mangou F; Tribouley-Duret J
Int J Parasitol; 1998 Apr; 28(4):641-51. PubMed ID: 9602389
[TBL] [Abstract][Full Text] [Related]
15. Quantitative characterization of hemozoin in Plasmodium berghei and vivax.
Pisciotta JM; Scholl PF; Shuman JL; Shualev V; Sullivan DJ
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):110-119. PubMed ID: 28279945
[TBL] [Abstract][Full Text] [Related]
16. Causal prophylactic activity of antihistaminic agents against Plasmodium yoelii nigeriensis infection in Swiss mice.
Singh N; Puri SK
Acta Trop; 1998 Jun; 69(3):255-60. PubMed ID: 9638277
[TBL] [Abstract][Full Text] [Related]
17. [Ca++ ion transport blockers as reversants of the drug resistance of malarial parasites. 1. The effect of verapamil on the resistance to chloroquine in vivo of Plasmodium berghei and in vitro of Plasmodium falciparum].
Rabinovich SA; Orlov VS; Dadasheva NR; Bukhtin BA; Maksakovskaia EV; Shcherbakov AM; Nguyen VK; Nguyen DS; Vu TT
Med Parazitol (Mosk); 1996; (1):18-22. PubMed ID: 8700004
[TBL] [Abstract][Full Text] [Related]
18. [In vitro potentiation of chloroquine activity in Plasmodium falciparum by ketotifen and cyproheptadine].
Quan H; Tang LH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):338-42. PubMed ID: 19157295
[TBL] [Abstract][Full Text] [Related]
19. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
Peters W; Irare SG; Ellis DS; Warhurst DC; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):567-79. PubMed ID: 6398032
[TBL] [Abstract][Full Text] [Related]
20. Haem polymerase as a novel target of antimalarial action of cyproheptadine.
Agrawal R; Tripathi R; Tekwani BL; Jain SK; Dutta GP; Shukla OP
Biochem Pharmacol; 2002 Nov; 64(9):1399-406. PubMed ID: 12392821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
